XIAONIXIAO NI8882NI, XIAOAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25376389Ni X, Jorgensen JL, Goswami M, Challagundla P, Decker WK, Kim YH, Duvic MAClinical cancer research : an official journal of the American Association for Cancer ResearchReduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome. Clin Cancer Res. 2015 Jan 15; 21(2):274-85.Clin Cancer Res2014-11-05T00:00:002014Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome.1515 Holcombe BlvdHouston77030-4009TXAuthorship 1742372Authorship 1812071HematopathologyStem Cell TransplantationSurgical OncologyMD AndersonMADELEINEDUVICMADELEINE DUVIC8533DUVIC, MADELEINEProfessorJEFFREY EGERSHENWALDJEFFREY E GERSHENWALD8667GERSHENWALD, JEFFREY EProfessor3.177370.0049414145research areas6.172540.016009216coauthor of228.3925.1665760similar to1128selected publicationsMICHAELTETZLAFFMICHAEL TETZLAFF9684TETZLAFF, MICHAELAssociate ProfessorPHYU PAUNGPHYU P AUNG9707AUNG, PHYU PAssistant ProfessorJEFFREY LJORGENSENJEFFREY L JORGENSEN9119JORGENSEN, JEFFREY LProfessorVICTORPRIETOVICTOR PRIETO8828PRIETO, VICTORProfessorCHITRAHOSINGCHITRA HOSING8863HOSING, CHITRAProfessorAMIN MAJIDALOUSIAMIN MAJID ALOUSI9278ALOUSI, AMIN MAJIDAssociate ProfessorAuthorship 2188291Authorship 2191203Authorship 2212554Authorship 2215762Authorship 2233552Authorship 2298951Authorship 231473211555580Ni X, Hazarika P, Zhang C, Talpur R, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchFas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Clin Cancer Res. 2001 Sep; 7(9):2682-92.Clin Cancer Res2001-09-01T00:00:002001Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?12006543Zhang C, Hazarika P, Ni X, Weidner DA, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchInduction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res. 2002 May; 8(5):1234-40.Clin Cancer Res2002-05-01T00:00:002002Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.15034511Apisarnthanarax N, Talpur R, Ward S, Ni X, Kim HW, Duvic MJournal of the American Academy of DermatologyTazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. J Am Acad Dermatol. 2004 Apr; 50(4):600-7.J Am Acad Dermatol2004-04-01T00:00:002004Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.15245439Zhang C, Ni X, Konopleva M, Andreeff M, Duvic MThe Journal of investigative dermatologyThe novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/S?zary syndrome cells. J Invest Dermatol. 2004 Aug; 123(2):380-7.J Invest Dermatol2004-08-01T00:00:002004The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/S?zary syndrome cells.17021762Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic MArchives of dermatological researchAbnormal expression of interleukin-23 in mycosis fungoides/S?zary syndrome lesions. Arch Dermatol Res. 2006 Dec; 298(7):353-6.Arch Dermatol Res2006-09-26T00:00:002006Abnormal expression of interleukin-23 in mycosis fungoides/S?zary syndrome lesions.21505396Ni X, Duvic MGiornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografiaDendritic cells and cutaneous T-cell lymphomas. G Ital Dermatol Venereol. 2011 Apr; 146(2):103-13.G Ital Dermatol Venereol2011-04-01T00:00:002011Dendritic cells and cutaneous T-cell lymphomas.22257096Shiue LH, Ni X, Prieto VG, Jorgensen JL, Curry JL, Goswami M, Sweeney SA, Duvic MInternational journal of dermatologyA case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone. Int J Dermatol. 2013 Sep; 52(9):1111-4.Int J Dermatol2012-01-18T00:00:002012A case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone.Authorship 2478463Authorship 2485023Authorship 2571834Authorship 259284616297208Zhang C, Richon V, Ni X, Talpur R, Duvic MThe Journal of investigative dermatologySelective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol. 2005 Nov; 125(5):1045-52.J Invest Dermatol2005-11-01T00:00:002005Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.16960145Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SRBloodPhase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2007 Jan 01; 109(1):31-9.Blood2006-09-07T00:00:002006Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).22515221Goswami M, Duvic M, Dougherty A, Ni XJournal of cutaneous pathologyIncreased Twist expression in advanced stage of mycosis fungoides and S?zary syndrome. J Cutan Pathol. 2012 May; 39(5):500-7.J Cutan Pathol2012-05-01T00:00:002012Increased Twist expression in advanced stage of mycosis fungoides and S?zary syndrome.23519332Shiue LH, Alousi AM, Wei C, Hosing CM, Duvic M, Ni XThe Journal of investigative dermatologyAugmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease. J Invest Dermatol. 2013 Aug; 133(8):2098-100.J Invest Dermatol2013-03-21T00:00:002013Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease.Authorship 267435115816832Ni X, Zhang C, Talpur R, Duvic MThe Journal of investigative dermatologyResistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. J Invest Dermatol. 2005 Apr; 124(4):741-50.J Invest Dermatol2005-04-01T00:00:002005Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.Authorship 2788991Authorship 2960055Authorship 301963225772268Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic MPhotodermatology, photoimmunology & photomedicineThe effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed. 2015 Jul; 31(4):184-94.Photodermatol Photoimmunol Photomed2015-03-28T00:00:002015The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.26551670Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, Xi L, Meng Q, Langridge T, Drummond J, Donehower LA, Doddapaneni H, Muzny DM, Gibbs RA, Wheeler DA, Duvic MNature geneticsGenomic profiling of S?zary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015 Dec; 47(12):1426-34.Nat Genet2015-11-09T00:00:002015Genomic profiling of S?zary syndrome identifies alterations of key T cell signaling and differentiation genes.14632211Duvic M, Ni X, Talpur R, Herne K, Schulz C, Sui D, Ward S, Joseph A, Hazarika PThe Journal of investigative dermatologyTazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol. 2003 Oct; 121(4):902-9.J Invest Dermatol2003-10-01T00:00:002003Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.74Professor10Assistant Professor14Associate ProfessorAuthorship 845108Authorship 848548Authorship 861074Authorship 865042Photodermatology Photoimmunology and PhotomedicineThe effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>-</sup> T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatology Photoimmunology and Photomedicine. 31:184-194.The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>-</sup> T cells in patients with leukemic cutaneous T-cell lymphomaNature GeneticsGenomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nature Genetics. 47:1426-1434.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesOncoImmunologyDepletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. OncoImmunology. 4:1-2.Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumabExpert Opinion on Orphan DrugsMogamulizumab in the treatment of cutaneous T cell lymphoma. Expert Opinion on Orphan Drugs. 4:1277-1280.Mogamulizumab in the treatment of cutaneous T cell lymphoma18480841Ni X, Richmond HM, Liao XM, Decker WK, Shiue LH, Shpall EJ, Duvic MThe Journal of investigative dermatologyInduction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA. J Invest Dermatol. 2008 Nov; 128(11):2631-2639.J Invest Dermatol2008-05-15T00:00:002008Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.D012751Disorders491590.868954Sezary SyndromeD017893Procedures32790.929529PhotopheresisD016410Disorders602930.765725Lymphoma, T-Cell, CutaneousD012878Disorders71446250.304227Skin NeoplasmsD009182Disorders743200.764751Mycosis FungoidesAuthorship 9101271Authorship 913600126140234Ni X, Langridge T, Duvic MOncoimmunologyDepletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. Oncoimmunology. 2015 Jul; 4(7):e1011524.Oncoimmunology2015-03-24T00:00:002015Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab.28977902Ni X, Zhang X, Hu CH, Langridge T, Tarapore RS, Allen JE, Oster W, Duvic MOncotargetONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-?B pathways. Oncotarget. 2017 Sep 22; 8(37):61761-61776.Oncotarget2017-06-27T00:00:002017ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-?B pathways.DermatologyPathologyDepartment of Pathology & ImmunologyImmunologyBaylor College of MedicineWILLIAMDECKERWILLIAM DECKER29.71073630000000-95.3966045000000036DECKER, WILLIAMProfessorAuthorship 947811831139332Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni XOncotargetBlood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 May 07; 10(34):3183-3197.Oncotarget2019-05-07T00:00:002019Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.Authorship 955740831534633Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni XOncotargetCorrection: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 Sep 10; 10(52):5492.Oncotarget2019-09-10T00:00:002019Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.Authorship 979354132187738Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic MPhotodermatology, photoimmunology & photomedicineCD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system. Photodermatol Photoimmunol Photomed. 2020 Jul; 36(4):290-298.Photodermatol Photoimmunol Photomed2020-04-16T00:00:002020CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system.Authorship 1030113134543492Ni X, Maiti S, Redko A, Bijani P, Duvic MPhotodermatology, photoimmunology & photomedicineMonitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2022 Mar; 38(2):158-168.Photodermatol Photoimmunol Photomed2021-09-26T00:00:002021Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis.Authorship 1081092837830594Velatooru LR, Hu CH, Bijani P, Wang X, Bojaxhi P, Chen H, Duvic M, Ni XCellsNew JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. Cells. 2023 09 29; 12(19).Cells2023-09-29T00:00:002023New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor